Eterna Therapeutics
ERNA
ERNA
53 hedge funds and large institutions have $52.1M invested in Eterna Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 51 → 53 (+2)
0.05% more ownership
Funds ownership: 0.03% → 0.08% (+0.05%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
53
Holding in Top 10
1
Calls
$638K
Puts
$311K
Top Buyers
| 1 | +$5.9M | |
| 2 | +$4.99M | |
| 3 | +$3.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.43M |
| 5 |
Morgan Stanley
New York
|
+$2.23M |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$453K | |
| 3 | -$191K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$110K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$108K |